Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Finance

New parallel fund offers Qiming LPs more healthcare exposure

Chinese VC’s newest offering among three new funds totaling $3.2B

By Jeff Cranmer, Executive Editor
July 16, 2022 12:43 AM UTC

A $925 million parallel fund among Qiming’s $3.2 billion trio of new vehicles will give the firm’s LPs an opportunity to increase their exposure to its healthcare investments.

It’s a new structure for the firm, Qiming Venture Partners’ Nisa Leung told BioCentury, with the parallel fund investing in every healthcare deal that the $1.5 billion USD Fund VIII backs. The firm raised the fund in four months, Leung said, and together the parallel fund and the main fund are double the size of Fund VII. ...

Get Unlimited Access
Continue reading with a free trial.
Start a Free TrialLog In
Or Purchase This Article

BCIQ Company Profiles

Qiming Venture Partners